- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Ansun Biopharma Inc.
Headquarters: San Diego, CA, United States of America
Website: http://www.ansunbiopharma.com...
Year Founded: 2003
Status: Private
BioCentury | Aug 2, 2022
Management Tracks
Mackison named CEO at Vico
Plus Arvinas hires Northcott as CCO, Manion joins Aclaris and updates from AnHeart, Gracell, Find and more
BioCentury | Jan 25, 2022
Management Tracks
Braunstein now CMO at Idorsia
Plus Kush, Haddach join RayzeBio and updates from Coherus, InterVenn, AsherBio and more
BioCentury | Apr 3, 2020
Product Development
COVID-19 roundup: Amgen taps Adaptive as its antibody therapeutic partner; plus Alnylam-Vir’s siRNA targets, Ansun’s data and more
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Feb 13, 2020
Emerging Company Profile
Pneumagen: out-competing viral sugar binding to prevent infection
Pneumagen targeting infections, cancer by co-opting and enhancing microbial carbohydrate binders
BioCentury | Oct 16, 2019
Financial News
China-heavy syndicate backs $80M series B for antiviral play Ansun
BioCentury | Oct 8, 2018
Company News
Management tracks: As Akcea shifts to commercialization, Crooke resigns from board
BioCentury | Jun 1, 2018
Finance
Distribution to innovation
How Sinopharm can help domestic, global portfolio companies access China market
BioCentury | May 18, 2018
Finance
Ansun’s China ambitions
How Chinese series A syndicate could help Ansun crack China’s antiviral market
Items per page:
1 - 10 of 12